SRS Investment Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-504,257
| Closed | -$9.81M | – | 25 |
|
|
2024
Q2 | $9.81M | Buy |
+504,257
| New | +$9.81M | 0.13% | 19 |
|
|
2024
Q1 | – | Sell |
-683,893
| Closed | -$38.3M | – | 27 |
|
|
2023
Q4 | $38.3M | Sell |
683,893
-365,317
| -35% | -$20.4M | 0.46% | 15 |
|
|
2023
Q3 | $43.3M | Sell |
1,049,210
-1,124,903
| -52% | -$46.4M | 0.62% | 14 |
|
|
2023
Q2 | $121M | Sell |
2,174,113
-831,314
| -28% | -$46.4M | 1.39% | 12 |
|
|
2023
Q1 | $168M | Hold |
3,005,427
| – | – | 2.41% | 7 |
|
|
2022
Q4 | $110M | Hold |
3,005,427
| – | – | 1.98% | 7 |
|
|
2022
Q3 | $85.6M | Buy |
3,005,427
+247,182
| +9% | +$7.04M | 1.68% | 9 |
|
|
2022
Q2 | $125M | Buy |
2,758,245
+2,548,380
| +1,214% | +$115M | 2.45% | 8 |
|
|
2022
Q1 | $16M | Hold |
209,865
| – | – | 0.18% | 26 |
|
|
2021
Q4 | $31.3M | Buy |
209,865
+169,414
| +419% | +$25.2M | 0.37% | 19 |
|
|
2021
Q3 | $5.89M | Buy |
+40,451
| New | +$5.89M | 0.08% | 23 |
|